Double umbilical cord blood transplantation for hematological malignancies: A long-term analysis from the SFGM-TC registry

Experimental Hematology

Volumn 41, Issue 11, 2013, Pages 924-933

  Wallet, Hélène Labussière ^a   Sobh, Mohamad ^a   Morisset, Stéphane ^a   Robin, Marie ^b   Fegueux, Nathalie ^c   Fürst, Sabine ^d   Mohty, Mohamad ^e,f,g,h   Deconinck, Eric ⁱ   Fouillard, Loïc ^f   Bordigoni, Pierre ^j   Rio, Bernard ^k   Sirvent, Anne ^l   Renaud, Marc ^m   Dhedin, Nathalie ⁿ   Tabrizi, Reza ^o   Maury, Sébastien ^p   Buzyn, Agnès ^q   Michel, Gérard ^r   Maillard, Natacha ^s   Cahn, Jean Yves ^t   Bay, Jacques Olivier ^u   Yakoub Agha, Ibrahim ^v   Huynh, Anne ^w   Schmidt Tanguy, Aline ^x   Lamy, Thierry ^y   Lioure, Bruno ^z   Raus, Nicole ^w   Marry, Evelyne ^aa   Garnier, Federico ^ab   Balère, Marie Lorraine ^aa   Gluckman, Eliane ^ac   Rocha, Vanderson ^b,ac   Socié, Gérard ^b   Blaise, Didier ^d   Milpied, Noël ^o   Michallet, Mauricette ^a   more..

^a CENTRE HOSPITALIER LYON SUD   (France)

^b SAINT LOUIS HOSPITAL   (France)

^c LAPEYRONIE HOSPITAL   (France)

^d INSTITUT PAOLI CALMETTES   (France)

^e NANTES UNIVERSITY HOSPITAL   (France)

^f HÔPITAL SAINT ANTOINE   (France)

^g SORBONNE UNIVERSITÉ   (France)

^h CENTRE DE RECHERCHE SAINT ANTOINE   (France)

ⁱ UNIVERSITY HOSPITAL JEAN MINJOZ   (France)

^j HÔPITAL D ENFANTS   (France)

^k HÔTEL DIEU   (France)

^l CENTRE HOSPITALIER UNIVERSITAIRE DE NICE   (France)

^m Societe Francaise de Greffe de Moelle et de Therapie Cellulaire (SFGM TC)   (France)

ⁿ ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

^o UNIVERSITÉ DE BORDEAUX   (France)

^p HENRI MONDOR HOSPITAL   (France)

^q HÔPITAL NECKER ENFANTS MALADES   (France)

^r TIMONE HOSPITAL   (France)

^s POITIERS UNIVERSITY HOSPITAL   (France)

^t HÔPITAL MICHALLON   (France)

^u UNIVERSITY HOSPITAL OF CLERMONT FERRAND   (France)

^v LILLE UNIVERSITY HOSPITAL   (France)

^w CHU PURPAN   (France)

^x ANGERS UNIVERSITY HOSPITAL   (France)

^y RENNES UNIVERSITY HOSPITAL   (France)

^z HÔPITAL DE HAUTEPIERRE   (France)

^aa Agence de la Biomedecine   (France)

^ab Réseau Français du Sang Placentaire   (France)

^ac EUROCORD   (France)

more..

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN A; METHOTREXATE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; STEROID;

ACUTE GRAFT VERSUS HOST DISEASE; ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ADULT; ARTICLE; CANCER INCIDENCE; CANCER REGRESSION; CHILD; CHIMERA; CHRONIC GRAFT VERSUS HOST DISEASE; CHRONIC LYMPHATIC LEUKEMIA; CHRONIC MYELOID LEUKEMIA; CONTROLLED STUDY; CORD BLOOD STEM CELL TRANSPLANTATION; FEMALE; HEMATOLOGIC MALIGNANCY; HEMATOLOGICAL PARAMETERS; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTIPLE MYELOMA; MYELOABLATIVE CONDITIONING; MYELODYSPLASTIC SYNDROME; MYELOPROLIFERATIVE DISORDER; NEUTROPHIL RECOVERY; NONHODGKIN LYMPHOMA; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; RECURRENCE RISK; REDUCED INTENSITY CONDITIONING; RETROSPECTIVE STUDY; SCHOOL CHILD;

ADOLESCENT; ADULT; AGED; CORD BLOOD STEM CELL TRANSPLANTATION; DISEASE-FREE SURVIVAL; FEMALE; FOLLOW-UP STUDIES; GRAFT VS HOST DISEASE; HEMATOLOGIC NEOPLASMS; HUMANS; MALE; MIDDLE AGED; RECURRENCE; REGISTRIES; RETROSPECTIVE STUDIES; SURVIVAL RATE; TIME FACTORS; TRANSPLANTATION CONDITIONING; TRANSPLANTATION, HOMOLOGOUS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84887606866     PISSN: 0301472X     EISSN: 18732399     Source Type: Journal    
DOI: 10.1016/j.exphem.2013.05.297     Document Type: Article

References (49)

1. Ueda T., Yoshida M., Yoshino H., et al. Hematopoietic capability of CD34+ cord blood cells: a comparison with CD34+ adult bone marrow cells. Int J Hematol 2001, 73:457-462.
2. Mayani H., Lansdorp P.M. Biology of human umbilical cord blood-derived hematopoietic stem/progenitor cells. Stem Cells 1998, 16:153-165.
3. Broxmeyer H.E., Hangoc G., Cooper S., et al. Growth characteristics and expansion of human umbilical cord blood and estimation of its potential for transplantation in adults. Proc Natl Acad Sci U S A 1992, 89:4109-4113.
4. Broxmeyer H.E., Douglas G.W., Hangoc G., et al. Human umbilical cord blood as a potential source of transplantable hematopoietic stem/progenitor cells. Proc Natl Acad Sci U S A 1989, 86:3828-3832.
5. Gabutti V., Timeus F., Ramenghi U., et al. Human cord blood progenitors: kinetics, regulation and their use for hemopoietic reconstitution. Bone Marrow Transplant 1993, 12(Suppl 1):84-86.
6. Brunstein C.G., Setubal D.C., Wagner J.E. Expanding the role of umbilical cord blood transplantation. Br J Haematol 2007, 137:20-35.
7. Barker J.N., Krepski T.P., DeFor T.E., Davies S.M., Wagner J.E., Weisdorf D.J. Searching for unrelated donor hematopoietic stem cells: availability and speed of umbilical cord blood versus bone marrow. Biol Blood Marrow Transplant 2002, 8:257-260.
8. Thomson B.G., Robertson K.A., Gowan D., et al. Analysis of engraftment, graft-versus-host disease, and immune recovery following unrelated donor cord blood transplantation. Blood 2000, 96:2703-2711.
9. Gluckman E., Rocha V. Cord blood transplantation: state of the art. Haematologica 2009, 94:451-454.
10. Gluckman E., Broxmeyer H.A., Auerbach A.D., et al. Hematopoietic reconstitution in a patient with Fanconi's anemia by means of umbilical-cord blood from an HLA-identical sibling. N Engl J Med 1989, 321:1174-1178.
11. Kurtzberg J., Laughlin M., Graham M.L., et al. Placental blood as a source of hematopoietic stem cells for transplantation into unrelated recipients. N Engl J Med 1996, 335:157-166.
12. Haspel R.L., Ballen K.K. Double cord blood transplants: filling a niche?. Stem Cell Rev 2006, 2:81-86.
13. Barker J.N., Weisdorf D.J., Wagner J.E. Creation of a double chimera after the transplantation of umbilical-cord blood from two partially matched unrelated donors. N Engl J Med 2001, 344:1870-1871.
14. Brunstein C.G., Barker J.N., Weisdorf D.J., et al. Umbilical cord blood transplantation after nonmyeloablative conditioning: impact on transplantation outcomes in 110 adults with hematologic disease. Blood 2007, 110:3064-3070.
15. Ballen K.K., Spitzer T.R., Yeap B.Y., et al. Double unrelated reduced-intensity umbilical cord blood transplantation in adults. Biol Blood Marrow Transplant 2007, 13:82-89.
16. Sideri A., Neokleous N., De La Grange P.B., et al. An overview of the progress on double umbilical cord blood transplantation. Haematologica 2011, 96:1213-1220.
17. Gluckman E., Rocha V., Arcese W., et al. Factors associated with outcomes of unrelated cord blood transplant: guidelines for donor choice. Exp Hematol 2004, 32:397-407.
18. Avery S., Shi W., Lubin M., et al. Influence of infused cell dose and HLA match on engraftment after double-unit cord blood allografts. Blood 2011, 117:3277-3285. quiz 3478.
19. Barker J.N., Byam C., Scaradavou A. How I treat: the selection and acquisition of unrelated cord blood grafts. Blood 2011, 117:2332-2339.
20. Giralt S., Ballen K., Rizzo D., et al. Reduced-intensity conditioning regimen workshop: defining the dose spectrum. Report of a workshop convened by the center for international blood and marrow transplant research. Biol Blood Marrow Transplant 2009, 15:367-369.
21. Barker J.N., Weisdorf D.J., DeFor T.E., Blazar B.R., Miller J.S., Wagner J.E. Rapid and complete donor chimerism in adult recipients of unrelated donor umbilical cord blood transplantation after reduced-intensity conditioning. Blood 2003, 102:1915-1919.
22. Newell L.F., Milano F., Nicoud I.B., et al. Early CD3 peripheral blood chimerism predicts the long-term engrafting unit following myeloablative double-cord blood transplantation. Biol Blood Marrow Transplant 2012, 18:1243-1249.
23. + T-cell response against the nonengrafted unit. Blood 2010, 115:757-765.
24. Glucksberg H., Storb R., Fefer A., et al. Clinical manifestations of graft-versus-host disease in human recipients of marrow from HL-A-matched sibling donors. Transplantation 1974, 18:295-304.
25. Shulman H.M., Sullivan K.M., Weiden P.L., et al. Chronic graft-versus-host syndrome in man. A long-term clinicopathologic study of 20 Seattle patients. Am J Med 1980, 69:204-217.
26. Fine J.P., Gray R.J. A proportional hazards model for subdistribution of a competing risk. J Am Stat Assoc 1999, 94:496-509.
27. Kaplan E.L., Meier P. Nonparametric estimation from inomplete observations. J Am Stat Assoc 1958, 53:457.
28. Cox D.R. Regression models and life tables. J Royal Stat Soc B 1972, 34:187-220.
29. Barker J.N., Weisdorf D.J., DeFor T.E., et al. Transplantation of 2 partiallyHLA-matched umbilical cord blood units to enhance engraftment in adults with hematologic malignancy. Blood 2005, 105:1343-1347.
30. Verneris M.R., Brunstein C.G., Barker J., et al. Relapse risk after umbilical cord blood transplantation: enhanced graft versus leukemia effect in recipients of two units. Blood 2009, 114:4293-4299.
31. MacMillan M.L., Weisdorf D.J., Brunstein C.G., et al. Acute graft-versus-host disease after unrelated donor umbilical cord blood transplantation: analysis of risk factors. Blood 2009, 113:2410-2415.
32. Rodrigues C.A., Sanz G., Brunstein C.G., et al. Analysis of risk factors for outcomes after unrelated cord blood transplantation in adults with lymphoid malignancies: a study by the Eurocord-Netcord and lymphoma working party of the European group for blood and marrow transplantation. J Clin Oncol 2009, 27:256-263.
33. Rocha V., Labopin M., Mohty M., et al. Outcomes after double unit unrelated cord blood transplantation (UCBT) compared with single UCBT in adults with acute leukemia in remission. An Eurocord and ALWP Collaboration study. Blood 2010, 116. Abstract 910.
34. Brunstein C.G., Gutman J.A., Weisdorf D.J., et al. Allogeneic hematopoietic cell transplantation for hematologic malignancy: relative risks and benefits of double umbilical cord blood. Blood 2010, 116:4693-4699.
35. Ponce D.M., Zheng J., Gonzales A.M., et al. Reduced late mortality risk contributes to similar survival after double-unit cord blood transplantation compared with related and unrelated donor hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 2011, 17:1316-1326.
36. Brunstein C.G., Fuchs E.J., Carter S.L., et al. Alternative donor transplantation after reduced intensity conditioning: results of parallel phase 2 trials using partially HLA-mismatched related bone marrow or unrelated double umbilical cord blood grafts. Blood 2011, 118:282-288.
37. Bradstock K., Hertzberg M., Kerridge I., et al. Single versus double unrelated umbilical cord blood units for allogeneic transplantation in adults with advanced haematological malignancies: a retrospective comparison of outcomes. Intern Med J 2009, 39:744-751.
38. Brunstein C.G. Umbilical cord blood transplantation for the treatment of hematologic malignancies. Cancer Control 2011, 18:222-236.
39. Kogler G., Enczmann J., Rocha V., Gluckman E., Wernet P. High-resolution HLA typing by sequencing for HLA-A, -B, -C, -DR, -DQ in 122 unrelated cord blood/patient pair transplants hardly improves long-term clinical outcome. Bone Marrow Transplant 2005, 36:1033-1041.
40. Willemze R., Rodrigues C.A., Labopin M., et al. KIR-ligand incompatibility in the graft-versus-host direction improves outcomes after umbilical cord blood transplantation for acute leukemia. Leukemia 2009, 23:492-500.
41. Weinreb S., Delgado J.C., Clavijo O.P., et al. Transplantation of unrelated cord blood cells. Bone Marrow Transplant 1998, 22:193-196.
42. Gertow J., Mattsson J.J., Uhlin M. Stable mixed double donor chimerism: absence of war doesn't necessarily mean peace. Chimerism 2010, 1:64-65.
43. Arachchillage D.R., Dalley C.D., Reilly J.T., Wilson G., Collins N., Snowden J.A. Long-term dual donor derived haematopoietic reconstitution following double unrelated cord blood transplantation-single unit dominance is not always the case. Br J Haematol 2010, 149:298-299.
44. Berglund S., Okas M., Gertow J., Uhlin M., Mattsson J. Stable mixed donor-donor chimerism after double cord blood transplantation. Int J Hematol 2009, 90:526-531.
45. Majhail N.S., Weisdorf D.J., Wagner J.E., Defor T.E., Brunstein C.G., Burns L.J. Comparable results of umbilical cord blood and HLA-matched sibling donor hematopoietic stem cell transplantation after reduced-intensity preparative regimen for advanced Hodgkin lymphoma. Blood 2006, 107:3804-3807.
46. Ramirez P., Wagner J.E., Defor T.E., et al. Factors predicting single-unit predominance after double umbilical cord blood transplantation. Bone Marrow Transplant 2012, 47:799-803.
47. Scaradavou A, Smith KM, Hawke R, etal. Cord blood units with low CD34+ cell viability have a low probability of engraftment after double unit transplantation. Biol Blood Marrow Transplant. 16:500-508.
48. Moretta A., Andriolo G., Lisini D., et al. Invitro evaluation of graft-versus-graft alloreactivity as a tool to identify the predominant cord blood unit before double cord blood transplantation. Biol Blood Marrow Transplant 2012, 18:1108-1118.
49. Eldjerou L.K., Chaudhury S., Baisre-de Leon A., et al. An invivo model of double-unit cord blood transplantation that correlates with clinical engraftment. Blood 2010, 116:3999-4006.